Connor, Clark & Lunn Investment Management Ltd.

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 1596800 VANCOUVER, A1

Position in PMVP

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$40,250

-$251,473 QoQ

Shares Held

32,460

-87.9% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $706,217,766 across 100 Biotechnology names. PMVP ranks #99 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	251,711	$112,399,029
2	IONS	Ionis Pharmaceuticals Inc	874,089	$65,635,343
3	ARWR	Arrowhead Pharmaceuticals, Inc.	836,981	$52,478,708
4	MIRM	Mirum Pharmaceuticals, Inc.	479,476	$44,293,992
5	REGN	Regeneron Pharmaceuticals, Inc.	32,164	$24,851,192
6	AXSM	Axsome Therapeutics, Inc.	134,792	$22,782,543
7	SRPT	Sarepta Therapeutics, Inc.	1,019,951	$22,194,133
8	TERN	Terns Pharmaceuticals, Inc.	384,681	$20,280,382

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$40,250	32,460	-87.9%	Shares	Sole	2026-05-11
2025-03-31	$291,723	267,636	-27.8%	Shares	Sole	2025-05-12
2024-12-31	$560,089	370,920	-15.9%	Shares	Sole	2025-02-10
2024-09-30	$657,125	441,024	+0.4%	Shares	Sole	2024-11-08
2024-06-30	$711,405	439,139	+1.2%	Shares	Sole	2024-08-09
2024-03-31	$737,550	433,853	+134.4%	Shares	Sole	2024-05-09
2023-12-31	$573,881	185,123	+9.1%	Shares	Sole	2024-02-09
2023-09-30	$1,041,951	169,699	+3.5%	Shares	Sole	2023-11-13
2023-06-30	$1,026,402	163,962	+5.1%	Shares	Sole	2023-08-10
2023-03-31	$744,396	156,058	+34.9%	Shares	Sole	2023-05-10
2022-12-31	$1,006,494	115,689	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.